Drugs / Liposo
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02749526 Background | Apr 2016 → Dec 2018 | esophageal cancer | The First Affiliated Hospital with Nanjing Medical University | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Liposo | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02749526 ↗ |